As of Feb 24
| +0.15 / +0.40%|
The 3 analysts offering 12-month price forecasts for Natus Medical Inc have a median target of 47.00, with a high estimate of 55.00 and a low estimate of 43.00. The median estimate represents a +23.85% increase from the last price of 37.95.
The current consensus among 4 polled investment analysts is to Buy stock in Natus Medical Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.